Intrinsiqs

Is Globus Medical, Inc. overvalued?

Globus Medical, Inc. (GMED) looks undervalued — trading about 59% below its fair value.

Undervalued
Current price $72.14 Fair value $114.54
Price
$72.14
Fair value
$114.54
Current P/E
16.2
Normal P/E
25.8
Market cap
$9.57B
Dividend yield
0.0%
Return on equity
11.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares GMED's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.